Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP).

Intensive Care Med · 2024 · PMC11447033 · PMID 39297945

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Notably, in a cohort of septic and septic shock patients, the J-Land 3S study showed a trend for lower mortality in patients treated with landiolol vs. standard of care [ 43 , 52 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.